| ASSET | YEAR | % RETURN |
|---|---|---|
Astrana Health (ASTH) | 2009 | 34,900% |
Metalla Royalty & Streaming (MTA) | 2009 | 6,272.29% |
Vanda Pharmaceuticals (VNDA) | 2009 | 2,280.95% |
MGP Ingredients (MGPI) | 2009 | 1,041.69% |
Mitek Systems (MITK) | 2009 | 950% |
Green Plains Renewable Energy (GPRE) | 2009 | 625.35% |
Achieve Life Sciences (ACHV) | 2009 | 587.65% |
Galiano Gold (GAU) | 2009 | 572.34% |
Gyre Therapeutics (GYRE) | 2009 | 485.43% |
Lithium Argentina (LAR) | 2009 | 474.76% |
International Tower Hill Mines (THM) | 2009 | 453.92% |
NewtekOne (NEWT) | 2009 | 413.73% |
Perion Network (PERI) | 2009 | 405.99% |
TriMas (TRS) | 2009 | 397.82% |
Canadian Solar (CSIQ) | 2009 | 370.15% |
Delcath Systems (DCTH) | 2009 | 363.62% |
IDT (IDT) | 2009 | 349.1% |
Perspective Therapeutics (CATX) | 2009 | 345% |
La-Z-Boy (LZB) | 2009 | 339.17% |
G Willi-Food International (WILC) | 2009 | 331.52% |
DeFi Technologies (DEFT) | 2009 | 321.36% |
BK Technologies (BKTI) | 2009 | 318.67% |
China Yuchai International (CYD) | 2009 | 289.21% |
Abeona Therapeutics (ABEO) | 2009 | 287.06% |
Eyepoint Pharmaceuticals (EYPT) | 2009 | 281.91% |
Small-cap stocks are treated as having a market cap between $300M and $2B.